Rare diseases
Investigational molecules
Locations
364 conditions with trials, the busiest first
1 206 trials across Europe, recruiting first
Study on Crovalimab for Preventing Painful Episodes in Sickle Cell Disease Patients
FranceStudy of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation
GermanyStudy of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia
ItalyStudy on the Safety and Effects of Crovalimab for Treating Vaso-Occlusive Episodes in Sickle Cell Disease Patients
FranceStudy of SLN124 for Patients with Polycythemia Vera
BulgariaStudy on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B
BelgiumStudy on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions
AustriaStudy of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
FranceStudy on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome
ItalyStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
BelgiumStudy on the Safety and Effectiveness of SerpinPC for Patients with Hemophilia B with Inhibitors
FranceStudy Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
AustriaThe therapies tested most often in Blood and lymphatic system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
